Kenya Association of Physicians Scientific Conference

Permanent URI for this collection

Browse

Recent Submissions

Now showing 1 - 10 of 24
  • Item
    The Two Faces of Influenza
    (Association of Kenya Physicians, 2007) Sabine, Arnoux; Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)
    Influenza is often misunderstood and underestimated. Influenza is not just “a bad cold”. Mainly spread through the air by coughing and sneezing, especially in closed public places: public transport, meeting rooms, etc. An infected person can transmit the virus to others from 1-2 days before flu symptoms start, and for 5 days afterwards. Influenza virus mutations: Influenza type A viruses mutate frequently, type B viruses mutate less frequently. Mutation enables the virus to bypass the population’s acquired immunity. Both the haemagglutinin and neuramidase surface antigens mutate.
  • Item
    Disparities of Health Care: Challenge to Physicians
    (Association of Kenya Physicians, 2007) Nyikal, James; Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)
    Challenges to the health sector: Finance and financial flows. Rapid growth of infrastructure. Human resource. Emerging diseases. Coordination. Legal framework. Poverty. Challenges to the physician: Health reforms. Leadership role and head of team. Role model. Cost of care and poverty. Ethics in compromised social environment. CPD. Curative care/disease prevention and health promotion. Perpetual dilemma.
  • Item
    Disparities in Health Care: Challenges to Physicians
    (Association of Kenya Physicians, 2007) Okelo, G. B. A.; Otieno, L. S.; Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)
    Many developing countries, including Kenya, face many challenges in health care some of which are outlined below: 1.1Relatively High fertility Rates 1.2 High mortality from preventable diseases 1.3Changing life style such as increasing tobacco consumption and increase in non-communicable diseases 1.4New and re-emerging diseases especially viral diseases 1.5Declining life expectancy 1.6Inadequate and poorly focused and/or targeted goals in disease control 1.7Civil unrest with its implications for health services 1.8Huge burdens of infectious diseases such as HIV/AIDS and tuberculosis 1.9Increasing burdens of non-communicable diseases such as Heart diseases, Cancer [such as prostate cancer, metabolic disorders like diabetes 10.0Slow pace in embracing new technology 11.0A steady rise in the socially disadvantaged groups i.e. women, children and the disabled populations whose access to reasonable health care is very limited. 12.0 Low immunization cover rate.
  • Item
    Chemotherapy for HIV associated Kaposi's sarcoma
    (Association of Kenya Physicians, 2007) Busakhala, N.; Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)
    HIV associated Kaposi’s sarcoma is a malignant, multifocal systemic disease that originates from the vascular endothelium. In contrast to the classical KS found in older men, in whom the tumors usually occur on the lower legs and feet, HIV-associated KS does not have a preferential pattern of localization.
  • Item
    β–adrenergic blockade, a renal perspective
    (Association of Kenya Physicians, 2007) McLigeyo, Seth; Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)
    Carvedilol • Third generation β–blocker (both β1and β2) • Possesses α1–adrenergic blocking properties. • β: αblocking ratio 7:1 to 3:1 • Antioxidant • Calcium antagonist
  • Item
    Slowing Disease Progression in Type 2 Diabetes: Latest Advances
    (Association of Kenya Physicians, 2007) Otieno, C. F.; Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)
    Background: Largest head-to-head, double-blind study of metformin, glyburide and rosiglitazone (N = 4,360). Primary objective: To compare the durability of glycemic control using rosiglitazone versus metformin or glyburide as initial monotherapy in patients with recently diagnosed type 2 diabetes. Design: Double-blind, randomized, controlled trial. Inclusion criteria: Type 2 diabetes ≤ 3 years, drug-naive, male and female, aged 30–75 years, FPG 126–180 mg/dl (7–10 mmol/l). Exclusion criteria: Previous use of glucose-lowering therapy, women of child-bearing potential, significant hepatic disease, renal impairment, unstable or severe angina, known CHF (NYHA Class I–IV), uncontrolled hypertension. Treatment duration: Treatment period: 4 to 6 years. Median duration of treatment: 4 years (rosiglitazone and metformin); 3.3 years (glyburide). Interventions: Rosiglitazone, metformin, glyburide.
  • Item
    Some basic facts on combination therapy
    (Association of Kenya Physicians, 2007) Kokwaro, Gilbert; Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)
    What are the problems with malaria? • The disease • The drugs • The policies • The finance COMBINATION THERAPY: DEFINITION • CT is the simultaneous use of two or more blood schizonticidal drugs with independent modes of action and different biochemical targets in the parasites • • CTs can be either fixed ratio combinations or multiple-drug therapy, in which components are co-administered in separate tablets or capsules.
  • Item
    Combination of OHA Therapy in Type 2 Diabetes Mellitus
    (Association of Kenya Physicians, 2007) Shah, Siddharth; Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)
    O.H.A. are the most common form of treatment of Type2 D.M. worldwide. When used judiciously they are important agents in the management of the most common form of diabetes. For economic, logistic and general effectiveness, oral agents are a dependable means of treating a large population of diabetics worldwide when used correctly.
  • Item
    Management of Arthritis
    (Association of Kenya Physicians, 2007) Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)
  • Item
    DD of Arthritis
    (Association of Kenya Physicians, 2007) Association of Kenya Physicians Scientific Conference (11th : Mar. 2007 : Eldoret, Kenya)
    Patient with Musculo-skeletal Complaints -Summary 1.Soft Tissue Rheumatism or Arthritis 2.Arthritis –Monoarticular-Crystals, Gout-Infective –acute –G+ve –ve-Chronic –Koch'sPolyarticular-:-(Asymmetrical)SSA -Reiter's, Reactive AS Psoriasis(Symetrical):-RA, SLE, DM. PM, Scleroderma APS, Vasculitis 3.Extraarticular features… 4.Laboratory, Imaging workup : DIAGNOSIS